International Journal of Molecular Sciences, Volume 23, Issue 12
2022 June-2 - 520 articles
Cover Story: Major advances in drug discovery and cancer-cell-targeted therapy may be achieved through the exploitation and immunomodulation of these drugs’ unique biological properties. A novel chemo-thermo-immuno therapy was developed by conjugating a melanogenesis substrate, N-propionyl cysteaminylphenol (NPrCAP: amine analog of tyrosine), with magnetite nanoparticles (MNPs). In this approach, NPrCAP provides a unique drug delivery system because of its selective incorporation into melanoma cells. It also functions as a melanoma-targeted therapeutic drug because of its production of highly reactive free radicals (melanoma-targeted chemotherapy). Moreover, MNPs can be utilized in thermo-immuno therapy due to the heat shock protein expression upon heat generation produced by MNPs exposed to an alternating magnetic field. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.